| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5903123 | Metabolism | 2014 | 8 Pages |
Abstract
ACEI/ARB use was associated with a lower risk of CVD events in older hypertensive patients with MetS, primarily due to a reduction in coronary events. The potential protective effect of ACEI/ARB on CVD events in older individuals with MetS will need further confirmation from prospective studies.
Keywords
NHLBITIAChFCHSHDLARBNCEPATPMyocardial infarctionAngiotensin converting enzyme inhibitorHeart Outcomes Prevention EvaluationEuropaHOPENational Cholesterol Education ProgramCABGtransient ischemic attackLIFEMetabolic syndromebody mass indexBMIhigh density lipoproteinlow density lipoproteinLDLMETSAngiotensin receptor blockerCardiovascular Health StudyInsulin resistanceACEI یا angiotensin convert enzyme inhibitorNational Heart Lung and Blood Institutecongestive heart failurehazard ratioAdult Treatment PanelCoronary artery bypass graft
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Hala H. Zreikat, Spencer E. Harpe, Patricia W. Slattum, D'arcy P. Mays, Paulina A. Essah, Kai I. Cheang,